Frequency of p53 mutations in human cancers. (A) Schematic picture... | Download Scientific Diagram
Pathogenesis of TP53-mutated Acute Myeloid leukemia | Laboratory of Daniel C. Link, M.D. | Washington University in St. Louis
Biomolecules | Free Full-Text | p53's Extended Reach: The Mutant p53 Secretome
Cancers | Free Full-Text | TP53 Combined Phenotype Score Is Associated with the Clinical Outcome of TP53-Mutated Myelodysplastic Syndromes
Targeting Cavity-Creating p53 Cancer Mutations with Small-Molecule Stabilizers: the Y220X Paradigm | ACS Chemical Biology
Frontiers | Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies
TP53 mutation spectrum in primary colorectal cancers. a Proportion of... | Download Scientific Diagram
Targeting a neoantigen derived from a common TP53 mutation | Science
TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection - eBioMedicine
Implications of driver genes associated with a high tumor mutation burden identified using next‑generation sequencing on immunotherapy in hepatocellular carcinoma
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden | Genome Medicine | Full Text
Scientists unveil chemotherapy resistance mechanism related to p53 mutation
The p53 network: cellular and systemic DNA damage responses in cancer and aging: Trends in Genetics
p53 Is the Most Frequently Mutated Gene in Cancer, but Can We Target It?
Clinical implications of subclonal TP53 mutations in acute myeloid leukemia | Haematologica
Gaining insights into relevance across cancers based on mutation features of TP53 gene - ScienceDirect
The p53 Protein: Mutations, Cancer & Cell Signalling - Assay Genie
LRP1B or TP53 mutations are associated with higher tumor mutational burden and worse survival in hepatocellular carcinoma
Gain-of-function p53 protein transferred via small extracellular vesicles promotes conversion of fibroblasts to a cancer-associated phenotype - ScienceDirect
Frontiers | A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer
TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection - eBioMedicine
Development of TP53 mutations over the course of therapy for acute myeloid leukemia - Alwash - 2021 - American Journal of Hematology - Wiley Online Library
